FDA Approves Tremfya for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis

THURSDAY, Oct. 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of plaque psoriasis and act